DSP (DSPG) 10-Q 10 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 03, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	DSP GROUP INC /DE/
Trading Symbol	DSPG
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		22,139,832
Amendment Flag	false
Entity Central Index Key	915,778
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and cash equivalents	$ 15,731	$ 20,544
Restricted deposit	170	623
Marketable securities and short-term deposits	11,974	11,508
Trade receivables	22,674	20,298
Deferred income taxes	780	775
Other accounts receivable and prepaid expenses	4,065	1,902
Inventories	14,067	15,635
TOTAL CURRENT ASSETS	69,461	71,285
PROPERTY AND EQUIPMENT, NET	3,446	2,843
LONG-TERM ASSETS:
Long-term marketable securities	92,206	92,269
Long-term prepaid expenses and lease deposits	1,233	1,162
Deferred income taxes	125	149
Severance pay fund	11,545	10,860
Investment in other companies	2,200	2,200
Intangible assets, net	4,493	5,135
Goodwill	5,276	5,276
	117,078	117,051
TOTAL ASSETS	189,985	191,179
CURRENT LIABILITIES:
Trade payables	15,250	15,282
Accrued compensation and benefits	7,830	9,408
Income tax accruals and payables	1,428	1,151
Accrued expenses and other accounts payable	5,105	5,852
Total current liabilities	29,613	31,693
LONG-TERM LIABILITIES:
Deferred income taxes	675	845
Accrued severance pay	11,610	10,929
Accrued pensions	1,005	1,089
Total long-term liabilities	13,290	12,863
Authorized shares: 50,000,000 shares at June 30, 2015 and December 31, 2014;
Issued and outstanding shares: 21,994,901 and 21,843,950 shares at June 30, 2015 and December 31, 2014, respectively	22	22
Additional paid-in capital	358,596	355,906
Treasury stock	(121,929)	(122,387)
Accumulated other comprehensive loss	(930)	(1,566)
Accumulated deficit	(88,677)	(85,352)
Total stockholders’ equity	147,082	146,623
Total liabilities and stockholders’ equity	$ 189,985	$ 191,179

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2015	Dec. 31, 2014
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	50,000,000	50,000,000
Common stock, issued	21,994,901	21,843,950
Common stock, outstanding	21,994,901	21,843,950

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income [Unaudited] - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenues		$ 37,247	$ 36,276	$ 75,282	$ 69,162
Cost of revenues (1)	[1]	22,012	21,495	44,512	41,367
Gross profit		15,235	14,781	30,770	27,795
Operating expenses:
Research and development, net (2)	[2]	8,855	8,025	17,971	16,230
Sales and marketing (3)	[3]	2,974	2,947	6,037	6,033
General and administrative (4)	[4]	2,460	2,644	4,981	5,361
Intangible assets amortization		321	397	642	794
Total operating expenses		14,610	14,013	29,631	28,418
Operating income (loss)		625	768	1,139	(623)
Interest and other income, net		291	297	626	709
Income before taxes on income		916	1,065	1,765	86
Taxes on income (income tax benefit)		186	(23)	262	(14)
Net income		$ 730	$ 1,088	$ 1,503	$ 100
Net income per share:
Basic (in Dollars per share)		$ 0.03	$ 0.05	$ 0.07	$ 0
Diluted (in Dollars per share)		$ 0.03	$ 0.05	$ 0.06	$ 0
Weighted average number of shares used in per share computations of net income:
Basic (in Shares)		22,064	21,983	22,115	22,180
Diluted (in Shares)		23,717	23,035	23,801	22,706
[1]	Includes equity-based compensation expense in the amount of $83 and $84 for the three months ended June 30, 2015 and 2014, respectively; and $153 and $166 for the six months ended June 30, 2015 and 2014, respectively.
[2]	Includes equity-based compensation expense in the amount of $613 and $657 for the three months ended June 30, 2015 and 2014, respectively; and $1,151 and $1,301 for the six months ended June 30, 2015 and 2014, respectively.
[3]	Includes equity-based compensation expense in the amount of $178 and $169 for the three months ended June 30, 2015 and 2014, respectively; and $330 and $331 for the six months ended June 30, 2015 and 2014, respectively.
[4]	Includes equity-based compensation expense in the amount of $537 and $551 for the three months ended June 30, 2014 and 2013, respectively; and $1,030 and $1,106 for the six months ended June 30, 2015 and 2014, respectively.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Income [Unaudited] (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Equity-based compensation expense included in cost of revenues	$ 83	$ 84	$ 153	$ 166
Equity-based compensation expenses included in research and development, net	613	657	1,151	1,301
Equity-based compensation expense included in sales and marketing	178	169	330	331
Equity-based compensation expense included in general and administrative	$ 537	$ 551	$ 1,030	$ 1,106

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net income:	$ 730	$ 1,088	$ 1,503	$ 100
Available-for-sale securities:
Changes in unrealized gain/loss	(549)	330	(134)	270
Reclassification adjustments for losses (gains) included in net income		(5)	26	(65)
Net change	(549)	325	(108)	205
Cash flow hedges:
Changes in unrealized gains/losses	454	6	162	9
Reclassification adjustments for losses included in net income	145		625	(2)
Net change	599	6	787	7
Change in unrealized components of defined benefit plans:
Amortization of actuarial loss and prior service benefit	5	2	10	5
Net change	5	2	10	5
Foreign currency translation adjustments, net	(5)	1	(53)	(5)
Other comprehensive income	50	334	636	212
Comprehensive income	$ 780	$ 1,422	$ 2,139	$ 312

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Net cash used in operating activities	$ 2,141	$ 567
Investing activities
Purchases of marketable securities	(15,342)	(37,296)
Proceeds from maturity of marketable securities	4,068	7,135
Proceeds from sales of marketable securities	10,332	31,989
Purchases of property and equipment	(1,202)	(698)
Decrease in restricted deposits	453
Net cash (used in) provided by investing activities	(1,691)	1,130
Financial activities
Purchase of treasury stock	(6,346)	(7,895)
Issuance of common stock and treasury stock upon exercise of stock options	1,138	442
Net cash used in financing activities	(5,208)	(7,453)
Decrease- in cash and cash equivalents	(4,758)	(5,756)
Erosion- due to exchange rate differences	(55)	(9)
Cash and cash equivalents at the beginning of the period	20,544	23,578
Cash and cash equivalents at the end of the period	$ 15,731	$ 17,813

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Net income				$ 100		$ 100
Change in accumulated other comprehensive income					$ 212	212
Purchase of treasury stock	$ (1)		$ (7,894)			(7,895)
Purchase of treasury stock (in Shares)	(909,000)
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan	$ 1		1,813	(982)		832
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan (in Shares)	185,000
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors			2,117	(1,675)		442
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors (in Shares)	217,000
Equity-based compensation		$ 2,904				2,904
Balance at Dec. 31, 2013	$ 22	350,494	(118,749)	(83,535)	(821)	147,411
Balance (in Shares) at Dec. 31, 2013	22,350,000
Balance at Jun. 30, 2014	$ 22	353,398	(122,713)	(86,092)	(609)	144,006
Balance (in Shares) at Jun. 30, 2014	21,843,000
Net income				1,088		1,088
Change in accumulated other comprehensive income					334	334
Purchase of treasury stock			(2,632)			(2,632)
Purchase of treasury stock (in Shares)	(313,000)
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors			279	(251)		28
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors (in Shares)	29,000
Equity-based compensation		1,461				1,461
Balance at Mar. 31, 2014	$ 22	351,937	(120,360)	(86,929)	(943)	143,727
Balance (in Shares) at Mar. 31, 2014	22,127,000
Balance at Jun. 30, 2014	$ 22	353,398	(122,713)	(86,092)	(609)	144,006
Balance (in Shares) at Jun. 30, 2014	21,843,000
Net income				1,503		1,503
Change in accumulated other comprehensive income					636	636
Purchase of treasury stock	$ (1)		(6,345)			$ (6,346)
Purchase of treasury stock (in Shares)	(550,000)					550,027
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan			1,124	(260)		$ 864
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan (in Shares)	116,000
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors	$ 1	26	5,679	(4,568)		1,138
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors (in Shares)	585,000
Equity-based compensation		2,664				2,664
Balance at Dec. 31, 2014	$ 22	355,906	(122,387)	(85,352)	(1,566)	146,623
Balance (in Shares) at Dec. 31, 2014	21,844,000
Balance at Jun. 30, 2015	$ 22	358,596	(121,929)	(88,677)	(930)	147,082
Balance (in Shares) at Jun. 30, 2015	21,995,000
Net income				730		730
Change in accumulated other comprehensive income					50	50
Purchase of treasury stock			(4,899)			(4,899)
Purchase of treasury stock (in Shares)	(425,000)
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors			1,879	(1,554)		325
Issuance of treasury stock upon exercise of stock options, stock appreciation rights and restricted share units by employees and directors (in Shares)	193,000
Equity-based compensation		1,411				1,411
Balance at Mar. 31, 2015	$ 22	357,185	(118,909)	(87,853)	(980)	149,465
Balance (in Shares) at Mar. 31, 2015	22,227,000
Balance at Jun. 30, 2015	$ 22	$ 358,596	$ (121,929)	$ (88,677)	$ (930)	$ 147,082
Balance (in Shares) at Jun. 30, 2015	21,995,000
[1]	Represents an amount lower than $1.

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE A—BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K of DSP Group, Inc. (the “Company”) for the year ended December 31, 2014.

Note 2 - Inventories

Note 2 - Inventories	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE B—INVENTORIES Inventories are stated at the lower of cost or market value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices, and historical and projected sales volume. Based on these evaluations, provisions are made in each period to write inventory down to its net realizable value. Inventories are composed of the following: June 30, 2015 December 31, 2014 (Unaudited) (Audited) Work-in-process $ 6,499 $ 6,795 Finished goods 7,568 8,840 $ 14,067 $ 15,635 Inventory write-off amounted to $311 and $11 for the six months ended June 30, 2015 and 2014, respectively.

Note 3 - Net Income (Loss) Per

Note 3 - Net Income (Loss) Per Share	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE C—NET INCOME (LOSS) PER SHARE Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. For the same periods, diluted net income (loss) per share further includes the effect of dilutive stock options, stock appreciation rights and restricted share units outstanding during the period, all in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 260 “Earnings per Share.” The following table sets forth the computation of basic and diluted net income (loss) per share: Three months ended June 30, Six months ended June 30, 2015 2014 2015 2014 Unaudited Net income $ 730 $ 1,088 $ 1,503 $ 100 Income per share: Basic $ 0.03 $ 0.05 $ 0.07 $ 0.00 Diluted $ 0.03 $ 0.05 $ 0.06 $ 0.00 Weighted average number of shares of common stock outstanding during the period used to compute basic net income per share (in thousands) 22,064 21,983 22,115 22,180 Incremental shares attributable to exercise of outstanding options, stock appreciation rights and restricted stock units (assuming proceeds would be used to purchase treasury stock) (in thousands) 1,653 1,052 1,686 526 Weighted average number of shares of common stock used to compute diluted net income per share (in thousands) 23,717 23,035 23,801 22,706

Note 4 - Marketable Securities

Note 4 - Marketable Securities and Time Deposits	6 Months Ended
	Jun. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	NOTE D—MARKETABLE SECURITIES and time deposits The Company accounts for investments in marketable securities in accordance with FASB ASC No.320-10 “Investments in Debt and Equity Securities.” Management determines the appropriate classification of its investments in government and corporate marketable debt securities at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies marketable securities as available-for-sale. Available-for-sale securities are carried at fair value, with the unrealized gains and losses, net of taxes, reported in other comprehensive income. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and interest are included in financial income, net. Interest and dividends on securities are included in financial income, net. The following is a summary of available-for-sale securities at June 30, 2015 and December 31, 2014: Amortized cost Unrealized gains (losses), net Fair value June 30, 2015 December 31, 2014 June 30, 2 015 December 31, 2014 June 30, 2015 December 31, 2014 (Unaudited) (Audited) (Unaudited) (Audited) (Unaudited) (Audited) Short term deposits $ 2,686 $ 2,599 $ - $ - $ 2,686 $ 2,599 U.S. GSE securities 23,725 21,085 (16 ) (34 ) 23,709 21,051 Corporate obligations 78,172 80,389 (387 ) (262 ) 77,785 80,127 $ 104,583 $ 104,072 $ (403 ) $ (296 ) $ 104,180 $ 103,777 The amortized cost of marketable debt securities and short-term deposits at June 30, 2015, by contractual maturities, is shown below : Unrealized gains (losses) Amortized cost Gains Losses Fair value Due in one year or less $ 11,968 $ 10 $ (4 ) $ 11,974 Due after one year to five years 92,615 90 (499 ) 92,206 $ 104,583 $ 100 $ (503 ) $ 104,180 The actual maturity dates may differ from the contractual maturities because debtors may have the right to call or prepay obligations without penalties. Management believes that as of June 30, 2015, the unrealized losses in the Company’s investments in all types of marketable securities were temporary and no impairment loss was realized in the Company’s condensed consolidated statement of income. The unrealized losses related to corporate obligations were primarily due to changes in interest rates. Because the Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at June 30, 2015. The total fair value of marketable securities with outstanding unrealized losses as of June 30, 2015 amounted to $63,252, while the unrealized losses for these marketable securities amounted to $503. Of the $503 unrealized losses outstanding as of June 30, 2015, a portion of which in the amount of $225 related to marketable securities that were in a loss position for more than 12 months and the remaining portion in the amount of $278 was related to marketable securities that were in a loss position for less than 12 months. Proceeds from maturity of available-for-sale marketable securities during the six months ended June 30, 2015 and 2014 were $4,068 and $7,135, respectively. Proceeds from sales of available-for-sale marketable securities during the six months ended June 30, 2015 and 2014 were $10,332 and $31,989, respectively. Net realized losses from the sale of available-for-sale securities for the six months ended June 30, 2015 were $26 compared to net realized gains for the six months ended June 30, 2014 of $65. The Company determines realized gains or losses on the sale of marketable securities based on a specific identification method. Marketable securities are periodically reviewed for impairment. If management concludes that any marketable security is impaired, management determines whether such impairment is other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value and the potential recovery period, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell the marketable security before recovery of cost basis. If any impairment is considered other-than-temporary, the marketable security is written down to its fair value through a corresponding charge to financial income, net.

Note 5 - Taxes On Income

Note 5 - Taxes On Income	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE e—TAXES ON Income The effective tax rate used in computing the provision for income taxes is based on projected fiscal year income before taxes, including estimated income by tax jurisdiction. Tax provision for the six months ended June 30, 2015 and 2014 does not include tax benefits associated with equity-based compensation expenses. The total amount of net unrecognized tax benefits was $1,277 and $1,031 at June 30, 2015 and December 31, 2014, respectively. The Company accrues interest and penalties, relating to unrecognized tax benefits, in its provision for income taxes. At June 30, 2015 and December 31, 2014, the Company had accrued interest and penalties relating to unrecognized tax benefits of $144 and $135, respectively. The Company intends to permanently reinvest earnings of its foreign operations and its current operating plans do not demonstrate a need to repatriate foreign earnings to fund the Company’s U.S. operations. However, if these funds were needed for the Company’s operations in the United States, the Company would be required to accrue and pay U.S. taxes as well as taxes in other countries to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

Note 6 - Significant Customers

Note 6 - Significant Customers	6 Months Ended
	Jun. 30, 2015
Significant Customers Disclosure [Abstract]
Significant Customers Disclosure [Text Block]	NOTE f—SIGNIFICANT CUSTOMERS The Company sells its products primarily through distributors and directly to original equipment manufacturers (OEMs) and original design manufacturers (ODMs) who incorporate the Company’s products into consumer products. The Company’s future performance will depend, in part, on the continued success of its distributors in marketing and selling its products. The loss of the Company’s distributors and the Company’s inability to obtain satisfactory replacements in a timely manner may harm the Company’s sales and results of operations. In addition, the Company expects that a limited number of customers, varying in identity from period-to-period, will account for a substantial portion of its revenues in any period. The loss of, or reduced demand for products from, any of the Company’s major customers could have a material adverse effect on the Company’s business, financial condition and results of operations. Sales to VTech Holdings Ltd. represented 31% and 37% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively. Sales to VTech represented 31% and 36% of the Company’s total revenues for the six months ended June 30, 2015 and 2014, respectively. Sales to Guo Wei Electronics Ltd. (“Guo Wei Electronics”) represented 12% and 8% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively. Sales to Guo Wei Electronics represented 11% and 8% of the Company’s total revenues for the six months ended June 30, 2015 and 2014, respectively. Revenues derived from sales through the Company’s distributor, Ascend Technology Inc., (“Ascend Technology”) accounted for 18% and 11% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively. Revenues derived from sales through Ascend Technology accounted for 17% and 11% of the Company’s total revenues for the six months ended June 30, 2015 and 2014, respectively. Revenues derived from sales through the Company’s distributor, Tomen Electronics Corporation (“Tomen Electronics”), accounted for 18% and 21% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 16% and 20% of the Company’s total revenues for the six months period ended June 30, 2015 and 2014, respectively. The Japanese market and the OEMs that operate in that market are among the largest suppliers in the world with significant market share in the U.S. market for residential wireless products. Tomen Electronics sells the Company’s products to a limited number of customers. One customer, Panasonic Communications Co., Ltd. (“Panasonic”), has continually accounted for a majority of the sales of Tomen Electronics. Sales to Panasonic through Tomen Electronics generated approximately 15% and 16% of the Company’s total revenues for the three months ended June 30, 2015 and 2014, respectively, and 13% and 14% of the Company’s total revenues for the six months period ended June 30, 2015 and 2014, respectively.

Note 7 - Derivative Instruments

Note 7 - Derivative Instruments	6 Months Ended
	Jun. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	NOTE G—DERIVATIVE INSTRUMENTS The Company accounts for derivative instruments in accordance with FASB. ASC No. 815 “Derivatives and Hedging” (“ASC 815”). Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward contracts and put options (collectively, “hedging contracts”). The policy, however, prohibits the Company from speculating on hedging contracts for profit. To protect against the increase in value of forecasted foreign currency cash flows resulting from salary and lease payments of its Israeli facilities denominated in the Israeli currency, the New Israeli Shekels (“NIS”), during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll and lease payments denominated in NIS for a period of one to twelve months with hedging contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges of these expenses. In accordance with ASC 815, for derivative instruments that are designated and qualify as a cash flow hedge (i.e. hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Any gain or loss on a derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item is recognized in current earnings during the period of change. As of June 30, 2015, the Company had no outstanding foreign exchange forward contracts and outstanding option contracts in the amount of $12,000. These hedging contracts do not contain any credit-risk-related contingency features. See Note K for information on the fair value of these hedging contracts. The fair value of derivative assets and derivative liabilities were $223 and $54, respectively, at June 30, 2015. The Company recorded a net amount of $169 in other accounts receivable and prepaid expenses in the condensed consolidated balance sheets at June 30, 2015. The amount recorded as loss in research and development expenses, sales and marketing expenses and general and administrative expenses in the condensed consolidated statements of income for the six months ended June 30, 2015 that resulted from the above referenced hedging transactions was $490, $49 and $86, respectively. The amount recorded as loss in research and development expenses, sales and marketing expenses and general and administrative expenses in the condensed consolidated statements of income for the three months ended June 30, 2015 that resulted from the above referenced hedging transactions was $114, $11 and $20, respectively. The fair value of the outstanding derivative instruments at June 30, 2015 and December 31, 2014 is summarized below: Fair Value of Derivative Instruments Balance Sheet Location As of June 30, As of December 31, Derivative Assets (Liabilities) Foreign exchange forward and options contracts Accrued expenses and other accounts payable - (618 ) Other accounts receivable and prepaid expenses (*) 169 - Total $ 169 $ (618 ) (*) Estimated to be reclassified into earnings during 2015 and 2016. The effect of derivative instruments in cash flow hedging transactions on income and other comprehensive income (“OCI”) for the three and six months ended June 30, 2015 and 2014 is summarized below: Gains on Derivatives Recognized in OCI for the three months ended June 30, for the six months ended June 30, 2015 2014 2015 2014 Foreign exchange forward and option contracts $ 454 $ 6 $ 162 $ 9 Gains (Losses) Reclassified from OCI into Income for the three months ended June 30 for the six months ended June 30, Location 2015 2014 2015 2014 Foreign exchange forward and option contracts Operating expenses $ (145) $ - $ (625) $ 2

Note 8 - Contingencies

Note 8 - Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE h—CONTINGENCIES From time to time, the Company may become involved in litigation relating to claims arising from its ordinary course of business. Also, as is typical in the semiconductor industry, the Company has been and may from time to time be notified of claims that the Company may be infringing patents or intellectual property rights owned by third parties. The Company currently believes that there are no claims or actions pending or threatened against it, the ultimate disposition of which would have a material adverse effect on the Company.

Note 9 - Equity-Based Compensat

Note 9 - Equity-Based Compensation	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE i—EQUITY-BASED COMPENSATION Grants for the Three Months ended June 30, 2015 and June 30, 2014: No employee stock options, stock appreciation rights (“SAR”) or restricted stock units (“RSU”) were granted during the three months ended June 30, 2015 and 2014. Employee Stock Benefit Plans As of June 30, 2015, the Company had two equity incentive plans from which the Company may grant future equity awards and three expired equity incentive plans from which no future equity awards may be granted but had outstanding equity awards granted prior to expiration. The Company also had one employee stock purchase plan. As of June 30, 2015, approximately 1,287,000 shares of common stock remain available for grant under the Company’s employee stock purchase plan and 1,055,000 shares of common stock remain available for grant under the Company’s equity incentive plans. The table below presents a summary of information relating to the Company’s stock option, RSU and SAR grants pursuant to its equity incentive plans: Number of Options/SARs / RSUs Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) (3) Aggregate Value (*) in thousands in thousands Outstanding at March 31, 2015 4,340 $ 5.95 Options granted - - RSUs granted - - Options / SARs / RSUs cancelled/forfeited/expired (2) - Options / SARs exercised and RSUs vested (326) $ 5.63 Outstanding at June 30, 2015 (1) 4,012 $ 5.97 3.72 $ 18,531 Exercisable at June 30, 2015 (2) 2,491 $ 7.5 3.17 $ 7,938 (*) Calculation of aggregate intrinsic value is based on the share price of the Company’s common stock on June 30, 2015 ($10.33 per share). (1) Due to the ceiling imposed on the SAR grants, the outstanding amount above can be exercised for a maximum of 3,391,000 shares of the Company’s common stock as of June 30, 2015. (2) Due to the ceiling imposed on the SAR grants, the exercisable amount above can be exercised for a maximum of 1,951,000 shares of the Company’s common stock as of June 30, 2015. (3) Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have indefinite contractual term. Additional information about stock options, SARs and RSUs outstanding and exercisable at June 30, 2015 with exercise prices above $10.33 per share (the closing price of the Company’s common stock on June 30, 2015) is as follows: Exercisable Unexercisable Total Exercise Prices Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Above $10.33 100 $ 19.27 179 $ 11.20 279 $ 14.09 Less than $10.33 2,391 $ 7.01 1,342 $ 2.43 3,733 $ 5.37 Total 2,491 $ 7.50 1,521 $ 3.47 4,012 $ 5.97 The Company’s aggregate equity-based compensation expense for the three months ended June 30, 2015 and 2014 totaled $1,411 and $1,461, respectively. The Company did not recognize any income tax benefit relating to the Company’s equity-based compensation expense for the three months ended June 30, 2015 and 2014. As of June 30, 2015, there was $5,338 of total unrecognized equity-based compensation expense related to unvested equity-based compensation awards granted under the Company’s equity incentive plans. This amount is expected to be recognized during the period from 2015 through 2019.

Note 10 - Pension Liability

Note 10 - Pension Liability	6 Months Ended
	Jun. 30, 2015
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE j—Pension Liability The information in this note represents the net periodic pension and post-retirement benefit costs and related components in accordance with FASB ASC No. 715 “Employers’ Disclosures about Pensions and Other Post-Retirement Benefits.” The components of net pension and post-retirement periodic benefit cost (income) for the six months ended June 30, 2015 and 2014 are as follows : June 30, 2015 June 30, 2014 Components of net periodic benefit cost: Service cost and amortization of loss $ 12 $ 8 Interest cost 9 15 Expected return on plan assets (2 ) (3 ) Net periodic benefit cost (income) $ 19 $ (20 ) The net pension liability as of June 30, 2015 amounted to $1,005.

Note 11 - Fair Value Measuremen

Note 11 - Fair Value Measurements	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Fair Value, Measurement Inputs, Disclosure [Text Block]	NOTE k—FAIR VALUE MEASUREMENTS Assets and Liabilities Measured at Fair Value on a Recurring Basis: The Company measures its cash equivalents, short-term deposits, marketable securities and foreign currency derivative contracts at fair value. Cash equivalents, short-term deposits and marketable securities are classified within Level 1 or Level 2 value hierarchies as they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. The following table provides information by value level for assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2015: Balance as of Fair Value Measurements June 30, 2015 Level 1 Level 2 Level 3 Description Assets Cash equivalents Money market mutual funds $ 1,254 $ 1,254 - - Short-term marketable securities and cash deposits: U.S. GSE securities $ 1,499 - $ 1,499 - Corporate debt securities $ 7,789 - $ 7,789 - Long-term marketable securities: U.S. GSE securities $ 22,210 - $ 22,210 - Corporate debt securities $ 69,996 - $ 69,996 - Derivative assets $ 169 - $ 169 - The following table provides information by value level for assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2014. Balance as of Fair Value Measurements December 31, 2014 Level 1 Level 2 Level 3 Description Assets: Cash equivalents: Money market mutual funds $ 2,746 $ 2,746 - - Short-term marketable securities and time deposits: U.S. GSE securities $ 1,499 - $ 1,499 - Corporate debt securities $ 7,410 - $ 7,410 - Long-term marketable securities: U.S. GSE securities $ 19,552 - $ 19,552 - Corporate debt securities $ 72,717 - $ 72,717 - Derivative liabilities $ (618 ) - $ (618 ) - In addition to the assets and liabilities described above, the Company’s financial instruments also include cash and cash equivalents, restricted and short-term deposits, trade receivables, other accounts receivable, trade payables, accrued expenses and other payables. The fair value of these financial instruments was not materially different from their carrying values at June 30, 2015 due to the short-term maturity of these instruments.

Note 12 -Stockholders' Equity

Note 12 -Stockholders' Equity	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE l—STOCKHOLDERS’ EQUITY During the first six months of 2015, the Company repurchased 550,027 shares of common stock at an average purchase price of $11.54 per share for an aggregate purchase price of $6,346. As of June 30, 2015, 653,574 shares of common stock remained authorized for repurchase under the Company's board-authorized share repurchase program. Repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with Accounting Principles Board Opinion No. 6, “Status of Accounting Research Bulletins” and charges the excess of the repurchase cost over issuance price using the weighted average method to accumulated deficit. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital. During the first six months of 2015, the Company issued approximately 701,000 shares of common stock out of treasury stock to employees who exercised their stock options, SARs or RSUs, or purchased shares from the Company’s 1993 Employee Stock Purchase Plan.

Note 13 - Segment Information

Note 13 - Segment Information	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE M SEGMENT INFORMATION Description of segments: The Company operates under three reportable segments. The Company's segment information has been prepared in accordance with ASC 280, "Segment Reporting." Operating segments are defined as components of an enterprise engaging in business activities about which separate financial information is available that is evaluated regularly by the Company's chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company's CODM is its Chief Executive Officer, who evaluates the Company's performance and allocates resources based on segment revenues and operating income. The Company's operating segments are as follows: Home, Office and Mobile. The classification of the Company’s business segments is based on a number of factors that management uses to evaluate, view and run its business operations, which include, but are not limited to, customer base, homogeneity of products and technology. A description of the types of products provided by each business segment is as follows: Home - Wireless chipset solutions for converged communication at home. Such solutions include integrated circuits targeted for cordless phones sold in retail or supplied by telecommunication service providers, residential gateway devices supplied by telecommunication service providers which integrate the DECT/CAT-iq functionality and also address home automation applications, as well as fixed-mobile convergence solutions. Office - Comprehensive solution for Voice-over-IP (VOIP) office products, including office solutions that offer businesses of all size low-cost VOIP terminals with converged voice and data applications. Mobile - Products for the mobile market that provides voice enhancement and far-end noise elimination targeted for mobile phone and mobile headsets. Segment data: The Company derives the results of its business segments directly from its internal management reporting system and by using certain allocation methods. The accounting policies the Company uses to derive business segment results are substantially the same as those the Company uses for consolidation of its financial statements. The CODM measures the performance of each business segment based on several metrics, including earnings from operations. The CODM uses these results, in part, to evaluate the performance of, and to assign resources to, each of the business segments. The Company does not allocate to its business segments certain operating expenses, which it manages separately at the corporate level. These unallocated costs include primarily amortization of purchased intangible assets, equity-based compensation expenses, and certain corporate governance costs. Selected operating results information for each business segment was as follows for the three months ended June 30, 2015 and 2014: Three months ended June 30, Revenues Income (loss) from operations 2015 2014 2015 2014 Home $ 32,055 $ 32,495 $ 7,112 $ 6,290 Office $ 5,192 $ 3,781 $ (1,102 ) $ (164 ) Mobile $ - $ - $ (3,150 ) $ (2,939 ) Total $ 37,247 $ 36,276 $ 2,860 $ 3,187 Selected operating results information for each business segment was as follows for the six months ended June 30, 2015 and 2014: Six months ended June 30, Revenues Income (loss) from operations 2015 2014 2015 2014 Home $ 66,406 $ 63,200 $ 14,288 $ 10,895 Office $ 8,876 $ 5,962 $ (1,715 ) $ (732 ) Mobile $ - $ - $ (6,987 ) $ (5,955 ) Total $ 75,282 $ 69,162 $ 5,586 $ 4,208 The reconciliation of segment operating results information to the Company’s consolidated financial information was as follows for the three and six months periods ended June 30, 2015: Three months Six months Income from operations $ 2,860 $ 5,586 Unallocated corporate, general and administrative expenses (503 ) (1,141 ) Equity-based compensation expenses (1,411 ) (2,664 ) Intangible assets amortization expenses (321 ) (642 ) Financial income, net 291 626 Total consolidated income before taxes $ 916 $ 1,765 The reconciliation of segment operating results information to the Company’s consolidated financial information was as follows for the three and six months ended June 30, 2014: Three months Six months Income from operations $ 3,187 $ 4,208 Unallocated corporate, general and administrative expenses (561 ) (1,133 ) Equity-based compensation expenses (1,461 ) (2,904 ) Intangible assets amortization expenses (397 ) (794 ) Financial income, net 297 709 Total consolidated income before taxes $ 1,065 $ 86

Note 13 - Accumulated Other Com

Note 13 - Accumulated Other Comprehensive Income	6 Months Ended
	Jun. 30, 2015
Accumulated Other Comprehensive Income Loss [Abstract]
Accumulated Other Comprehensive Income Loss [Text Block]	NOTE N —ACCUMULATED OTHER COMPREHENSIVE INCOME The following table summarizes the changes in accumulated balances of other comprehensive income for the three months ended June 30, 2015: Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Unrealized gains (losses) on components of defined benefit plans Unrealized gains (losses) on foreign currency translation Total Beginning balance $ 146 $ (430 ) $ (430 ) $ (266 ) $ (980 ) Other comprehensive income (loss) before reclassifications (549 ) 454 - (5 ) (100 ) Losses reclassified from accumulated other comprehensive income (loss) - 145 5 - 150 Net current period other comprehensive income (loss) (549 ) 599 5 (5 ) 50 Ending balance $ (403 ) $ 169 $ (425 ) $ (271 ) $ (930 ) The following table provides details about reclassifications out of accumulated other comprehensive income for the three months ended June 30, 2015: Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statement of Income Losses on available-for-sale marketable securities - Financial income, net - Provision for income taxes - Total, net of income taxes Losses on cash flow hedges 114 Research and development 11 Sales and marketing 20 General and administrative 145 Total, before income taxes - Provision for income taxes 145 Total, net of income taxes Losses on components of defined benefit plans 3 Research and development 2 Sales and marketing 5 Total, before income taxes - Provision for income taxes 5 Total, net of income taxes Total reclassifications for the period $ 150 Total, net of income taxes The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the six months ended June 30, 2015: Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on Cash Flow Hedges Unrealized gains (losses) on components of defined benefit plans Unrealized gains (losses) on foreign currency translation Total Beginning balance $ (295 ) $ (618 ) $ (435 ) $ (218 ) $ (1,566 ) Other comprehensive income (loss) before reclassifications (134 ) 162 - (53 ) (25 ) Losses reclassified from accumulated other comprehensive income (loss) 26 625 10 - 661 Net current period other comprehensive income (loss) (108 ) 787 10 (53 ) 636 Ending balance $ (403 ) $ 169 $ (425 ) (271 ) $ (930 ) The following table provides details about reclassifications out of accumulated other comprehensive income for the six months ended June 30, 2015: Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statement of Income Losses on available-for-sale marketable securities $ 26 Financial income, net - Provision for income taxes 26 Total, net of income taxes Losses on cash flow hedges 490 Research and development 49 Sales and marketing 86 General and administrative 625 Total, before income taxes - Provision for income taxes 625 Total, net of income taxes Losses on components of defined benefit plans 6 Research and development 4 Sales and marketing 10 Total, before income taxes - Provision for income taxes 10 Total, net of income taxes Total reclassifications for the period $ 661 Total, net of income taxes

Note 14 - Government Grants

Note 14 - Government Grants	6 Months Ended
	Jun. 30, 2015
Government Grants [Abstract]
Government Grants [Text Block]	NOTE O GOVERNMENT GRANTS Government grants received by the Company’s Israeli subsidiary relating to categories of operating expenditures are credited to the consolidated statements of income during the period during which the expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israeli Office of the Chief Scientist ("OCS") for funding certain approved research and development projects are recognized at the time when the Company’s Israeli subsidiary is entitled to such grants, on the basis of the related costs incurred, and are included as a deduction from research and development expenses, net. The Company recorded grants in the amount of $1,550 and $1,156 for the three months ended June 30, 2015 and 2014, respectively. The Company recorded grants in the amount of $1,614 and $2,037 for the six months ended June 30, 2015 and 2014, respectively. The Company’s Israeli subsidiary is obligated to pay royalties amounting to 5% of the sales of certain products the development of which received grants from the OCS in previous years. The obligation to pay these royalties is contingent on actual sales of such products. Grants received from the OCS may become repayable if certain criteria under the grants are not met. In addition, the grants may be required to be repaid with a multiple of up to six times the initial grant amount in case the technology that was developed using these grants are transferred, directly or indirectly, to a third party.

Note 2 - Inventories (Tables)

Note 2 - Inventories (Tables)	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	June 30, 2015 December 31, 2014 (Unaudited) (Audited) Work-in-process $ 6,499 $ 6,795 Finished goods 7,568 8,840 $ 14,067 $ 15,635

Note 3 - Net Income (Loss) Pe25

Note 3 - Net Income (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended June 30, Six months ended June 30, 2015 2014 2015 2014 Unaudited Net income $ 730 $ 1,088 $ 1,503 $ 100 Income per share: Basic $ 0.03 $ 0.05 $ 0.07 $ 0.00 Diluted $ 0.03 $ 0.05 $ 0.06 $ 0.00 Weighted average number of shares of common stock outstanding during the period used to compute basic net income per share (in thousands) 22,064 21,983 22,115 22,180 Incremental shares attributable to exercise of outstanding options, stock appreciation rights and restricted stock units (assuming proceeds would be used to purchase treasury stock) (in thousands) 1,653 1,052 1,686 526 Weighted average number of shares of common stock used to compute diluted net income per share (in thousands) 23,717 23,035 23,801 22,706

Note 4 - Marketable Securitie26

Note 4 - Marketable Securities and Time Deposits (Tables)	6 Months Ended
	Jun. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities [Table Text Block]	Amortized cost Unrealized gains (losses), net Fair value June 30, 2015 December 31, 2014 June 30, 2 015 December 31, 2014 June 30, 2015 December 31, 2014 (Unaudited) (Audited) (Unaudited) (Audited) (Unaudited) (Audited) Short term deposits $ 2,686 $ 2,599 $ - $ - $ 2,686 $ 2,599 U.S. GSE securities 23,725 21,085 (16 ) (34 ) 23,709 21,051 Corporate obligations 78,172 80,389 (387 ) (262 ) 77,785 80,127 $ 104,583 $ 104,072 $ (403 ) $ (296 ) $ 104,180 $ 103,777
Investments Classified by Contractual Maturity Date [Table Text Block]	Unrealized gains (losses) Amortized cost Gains Losses Fair value Due in one year or less $ 11,968 $ 10 $ (4 ) $ 11,974 Due after one year to five years 92,615 90 (499 ) 92,206 $ 104,583 $ 100 $ (503 ) $ 104,180

Note 7 - Derivative Instrumen27

Note 7 - Derivative Instruments (Tables)	6 Months Ended
	Jun. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	Fair Value of Derivative Instruments Balance Sheet Location As of June 30, As of December 31, Derivative Assets (Liabilities) Foreign exchange forward and options contracts Accrued expenses and other accounts payable - (618 ) Other accounts receivable and prepaid expenses (*) 169 - Total $ 169 $ (618 )
Derivative Instruments, Gain (Loss) [Table Text Block]	Gains on Derivatives Recognized in OCI for the three months ended June 30, for the six months ended June 30, 2015 2014 2015 2014 Foreign exchange forward and option contracts $ 454 $ 6 $ 162 $ 9 Gains (Losses) Reclassified from OCI into Income for the three months ended June 30 for the six months ended June 30, Location 2015 2014 2015 2014 Foreign exchange forward and option contracts Operating expenses $ (145) $ - $ (625) $ 2

Note 9 - Equity-Based Compens28

Note 9 - Equity-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Activity [Table Text Block]	Number of Options/SARs / RSUs Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) (3) Aggregate Value (*) in thousands in thousands Outstanding at March 31, 2015 4,340 $ 5.95 Options granted - - RSUs granted - - Options / SARs / RSUs cancelled/forfeited/expired (2) - Options / SARs exercised and RSUs vested (326) $ 5.63 Outstanding at June 30, 2015 (1) 4,012 $ 5.97 3.72 $ 18,531 Exercisable at June 30, 2015 (2) 2,491 $ 7.5 3.17 $ 7,938
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Exercisable Unexercisable Total Exercise Prices Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Number of Options/ SARs / RSUs (in thousands) Weighted Average Exercise Price Above $10.33 100 $ 19.27 179 $ 11.20 279 $ 14.09 Less than $10.33 2,391 $ 7.01 1,342 $ 2.43 3,733 $ 5.37 Total 2,491 $ 7.50 1,521 $ 3.47 4,012 $ 5.97

Note 10 - Pension Liability (Ta

Note 10 - Pension Liability (Tables)	6 Months Ended
	Jun. 30, 2015
Compensation and Retirement Disclosure [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	June 30, 2015 June 30, 2014 Components of net periodic benefit cost: Service cost and amortization of loss $ 12 $ 8 Interest cost 9 15 Expected return on plan assets (2 ) (3 ) Net periodic benefit cost (income) $ 19 $ (20 )

Note 11 - Fair Value Measurem30

Note 11 - Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance as of Fair Value Measurements June 30, 2015 Level 1 Level 2 Level 3 Description Assets Cash equivalents Money market mutual funds $ 1,254 $ 1,254 - - Short-term marketable securities and cash deposits: U.S. GSE securities $ 1,499 - $ 1,499 - Corporate debt securities $ 7,789 - $ 7,789 - Long-term marketable securities: U.S. GSE securities $ 22,210 - $ 22,210 - Corporate debt securities $ 69,996 - $ 69,996 - Derivative assets $ 169 - $ 169 - Balance as of Fair Value Measurements December 31, 2014 Level 1 Level 2 Level 3 Description Assets: Cash equivalents: Money market mutual funds $ 2,746 $ 2,746 - - Short-term marketable securities and time deposits: U.S. GSE securities $ 1,499 - $ 1,499 - Corporate debt securities $ 7,410 - $ 7,410 - Long-term marketable securities: U.S. GSE securities $ 19,552 - $ 19,552 - Corporate debt securities $ 72,717 - $ 72,717 - Derivative liabilities $ (618 ) - $ (618 ) -

Note 13 - Segment Information (

Note 13 - Segment Information (Tables)	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three months ended June 30, Revenues Income (loss) from operations 2015 2014 2015 2014 Home $ 32,055 $ 32,495 $ 7,112 $ 6,290 Office $ 5,192 $ 3,781 $ (1,102 ) $ (164 ) Mobile $ - $ - $ (3,150 ) $ (2,939 ) Total $ 37,247 $ 36,276 $ 2,860 $ 3,187 Six months ended June 30, Revenues Income (loss) from operations 2015 2014 2015 2014 Home $ 66,406 $ 63,200 $ 14,288 $ 10,895 Office $ 8,876 $ 5,962 $ (1,715 ) $ (732 ) Mobile $ - $ - $ (6,987 ) $ (5,955 ) Total $ 75,282 $ 69,162 $ 5,586 $ 4,208
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Three months Six months Income from operations $ 2,860 $ 5,586 Unallocated corporate, general and administrative expenses (503 ) (1,141 ) Equity-based compensation expenses (1,411 ) (2,664 ) Intangible assets amortization expenses (321 ) (642 ) Financial income, net 291 626 Total consolidated income before taxes $ 916 $ 1,765 Three months Six months Income from operations $ 3,187 $ 4,208 Unallocated corporate, general and administrative expenses (561 ) (1,133 ) Equity-based compensation expenses (1,461 ) (2,904 ) Intangible assets amortization expenses (397 ) (794 ) Financial income, net 297 709 Total consolidated income before taxes $ 1,065 $ 86

Note 13 - Accumulated Other C32

Note 13 - Accumulated Other Comprehensive Income (Tables)	6 Months Ended
	Jun. 30, 2015
Accumulated Other Comprehensive Income Loss [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Unrealized gains (losses) on components of defined benefit plans Unrealized gains (losses) on foreign currency translation Total Beginning balance $ 146 $ (430 ) $ (430 ) $ (266 ) $ (980 ) Other comprehensive income (loss) before reclassifications (549 ) 454 - (5 ) (100 ) Losses reclassified from accumulated other comprehensive income (loss) - 145 5 - 150 Net current period other comprehensive income (loss) (549 ) 599 5 (5 ) 50 Ending balance $ (403 ) $ 169 $ (425 ) $ (271 ) $ (930 ) Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on Cash Flow Hedges Unrealized gains (losses) on components of defined benefit plans Unrealized gains (losses) on foreign currency translation Total Beginning balance $ (295 ) $ (618 ) $ (435 ) $ (218 ) $ (1,566 ) Other comprehensive income (loss) before reclassifications (134 ) 162 - (53 ) (25 ) Losses reclassified from accumulated other comprehensive income (loss) 26 625 10 - 661 Net current period other comprehensive income (loss) (108 ) 787 10 (53 ) 636 Ending balance $ (403 ) $ 169 $ (425 ) (271 ) $ (930 )
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statement of Income Losses on available-for-sale marketable securities - Financial income, net - Provision for income taxes - Total, net of income taxes Losses on cash flow hedges 114 Research and development 11 Sales and marketing 20 General and administrative 145 Total, before income taxes - Provision for income taxes 145 Total, net of income taxes Losses on components of defined benefit plans 3 Research and development 2 Sales and marketing 5 Total, before income taxes - Provision for income taxes 5 Total, net of income taxes Total reclassifications for the period $ 150 Total, net of income taxes Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statement of Income Losses on available-for-sale marketable securities $ 26 Financial income, net - Provision for income taxes 26 Total, net of income taxes Losses on cash flow hedges 490 Research and development 49 Sales and marketing 86 General and administrative 625 Total, before income taxes - Provision for income taxes 625 Total, net of income taxes Losses on components of defined benefit plans 6 Research and development 4 Sales and marketing 10 Total, before income taxes - Provision for income taxes 10 Total, net of income taxes Total reclassifications for the period $ 661 Total, net of income taxes

Note 2 - Inventories (Details)

Note 2 - Inventories (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Inventory Disclosure [Abstract]
Inventory Write-down	$ 311	$ 11

Note 2 - Inventories (Details)

Note 2 - Inventories (Details) - Components of Inventories - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Components of Inventories [Abstract]
Work-in-process	$ 6,499	$ 6,795
Finished goods	7,568	8,840
	$ 14,067	$ 15,635

Note 3 - Net Income (Loss) Pe35

Note 3 - Net Income (Loss) Per Share (Details) - Net Income (Loss) Per Share - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net Income (Loss) Per Share [Abstract]
Net income (in Dollars)	$ 730	$ 1,088	$ 1,503	$ 100
Income per share:
Basic (in Dollars per share)	$ 0.03	$ 0.05	$ 0.07	$ 0
Diluted (in Dollars per share)	$ 0.03	$ 0.05	$ 0.06	$ 0
Weighted average number of shares of common stock outstanding during the period used to compute basic net income per share (in thousands)	22,064	21,983	22,115	22,180
Incremental shares attributable to exercise of outstanding options, stock appreciation rights and restricted stock units (assuming proceeds would be used to purchase treasury stock) (in thousands)	1,653	1,052	1,686	526
Weighted average number of shares of common stock used to compute diluted net income per share (in thousands)	23,717	23,035	23,801	22,706

Note 4 - Marketable Securitie36

Note 4 - Marketable Securities and Time Deposits (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Investments, Debt and Equity Securities [Abstract]
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net	$ 0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	63,252,000
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax	503,000
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	225,000
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	278,000
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities	4,068,000	$ 7,135,000
Proceeds from Sale of Available-for-sale Securities	10,332,000	31,989,000
Available-for-sale Securities, Gross Realized Losses	$ 26,000
Available-for-sale Securities, Gross Realized Gains		$ 65,000

Note 4 - Marketable Securitie37

Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Securities and Time Deposits - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	$ 104,583	$ 104,072
Marketable securities and time deposits, unrealized gains (losses), net	(403)	(296)
Marketable securities and time deposits, estimated fair value	104,180	103,777
Short-term Deposits [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	2,686	2,599
Marketable securities and time deposits, estimated fair value	2,686	2,599
US Government-sponsored Enterprises Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	23,725	21,085
Marketable securities and time deposits, unrealized gains (losses), net	(16)	(34)
Marketable securities and time deposits, estimated fair value	23,709	21,051
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	78,172	80,389
Marketable securities and time deposits, unrealized gains (losses), net	(387)	(262)
Marketable securities and time deposits, estimated fair value	$ 77,785	$ 80,127

Note 4 - Marketable Securitie38

Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	$ 104,583	$ 104,072
Marketable debt securities, estimated fair value	104,180	$ 103,777
Debt Securities [Member]
Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	104,583
Marketable debt securities, unrealized gains	100
Marketable debt securities, unrealized losses	(503)
Marketable debt securities, estimated fair value	104,180
Debt Securities [Member] | Due in One Year or Less [Member]
Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	11,968
Marketable debt securities, unrealized gains	10
Marketable debt securities, unrealized losses	(4)
Marketable debt securities, estimated fair value	11,974
Debt Securities [Member] | Due After One Year to Five Years [Member]
Note 4 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	92,615
Marketable debt securities, unrealized gains	90
Marketable debt securities, unrealized losses	(499)
Marketable debt securities, estimated fair value	$ 92,206

Note 5 - Taxes On Income (Detai

Note 5 - Taxes On Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	$ 0	$ 0	$ 0	$ 0
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	1,277		1,277		$ 1,031
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$ 144		$ 144		$ 135

Note 6 - Significant Customers

Note 6 - Significant Customers (Details) - Sales Revenue, Net [Member] - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
VTech Holdings Ltd. [Member]
Note 6 - Significant Customers (Details) [Line Items]
Concentration Risk, Percentage	31.00%	37.00%	31.00%	36.00%
Guo Wei Electronics [Member]
Note 6 - Significant Customers (Details) [Line Items]
Concentration Risk, Percentage	12.00%	8.00%	11.00%	8.00%
Ascend Technology Inc [Member]
Note 6 - Significant Customers (Details) [Line Items]
Concentration Risk, Percentage	18.00%	11.00%	17.00%	11.00%
Tomen Electronics Corporation [Member]
Note 6 - Significant Customers (Details) [Line Items]
Concentration Risk, Percentage	18.00%	21.00%	16.00%	20.00%
Panasonic Communications Corporation [Member]
Note 6 - Significant Customers (Details) [Line Items]
Concentration Risk, Percentage	15.00%	16.00%	13.00%	14.00%

Note 7 - Derivative Instrumen41

Note 7 - Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Asset	$ 223	$ 223
Derivative Liability	54	54
Derivative Assets (Liabilities), at Fair Value, Net	169	169		$ (618)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(145)	(625)	$ 2
Foreign Exchange Contract [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Price Risk Cash Flow Hedge Asset, at Fair Value	0	0
Foreign Exchange Option [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Price Risk Cash Flow Hedge Asset, at Fair Value	12,000	12,000
Foreign Exchange Forward Contracts and Put Options [Member] | Prepaid Expenses and Other Current Assets [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net	169	169
Research and Development Expense [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(114)	(490)
Selling and Marketing Expense [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(11)	(49)
General and Administrative Expense [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ (20)	$ (86)
Minimum [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Instrument Hedging Period		1 month
Maximum [Member]
Note 7 - Derivative Instruments (Details) [Line Items]
Derivative Instrument Hedging Period		12 months

Note 7 - Derivative Instrumen42

Note 7 - Derivative Instruments (Details) - The Fair Value of the Derivative Instruments - USD ($) $ in Thousands		Jun. 30, 2015	Dec. 31, 2014
Derivative Assets (Liabilities)
Foreign exchange forward and options contracts		$ 169	$ (618)
Foreign Exchange Forward Contracts and Put Options [Member] | Accounts Payable and Accrued Liabilities [Member]
Derivative Assets (Liabilities)
Foreign exchange forward and options contracts	[1]		$ (618)
Foreign Exchange Forward Contracts and Put Options [Member] | Prepaid Expenses and Other Current Assets [Member]
Derivative Assets (Liabilities)
Foreign exchange forward and options contracts		$ 169
[1]	Estimated to be reclassified into earnings during 2015 and 2016.

Note 7 - Derivative Instrumen43

Note 7 - Derivative Instruments (Details) - Effect of Derivative Instruments in Cash Flow Hedging Transactions on Income and Other Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange forward and option contracts			$ 162
Foreign exchange forward and option contracts	$ (145)		$ (625)	$ 2
Gains Losses on Derivatives Recognized in OCI [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange forward and option contracts	$ 454	$ 6		$ 9

Note 9 - Equity-Based Compens44

Note 9 - Equity-Based Compensation (Details) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended		36 Months Ended	42 Months Ended
	Jun. 30, 2015USD ($)$ / sharesshares	Jun. 30, 2014USD ($)shares	Jun. 30, 2015USD ($)$ / sharesshares	Jun. 30, 2014USD ($)	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2012	Jun. 30, 2015USD ($)$ / sharesshares
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Number of Equity Incentive Plans	2		2					2
Share-based Compensation Arrangement byShare-based Payment Award, Number of Expired Equity Incentive Plans	3		3					3
Share-based Compensation Arrangement by Share-based Payment Award, Number of Employee Purchase Plans	1		1					1
Share Price (in Dollars per share) | $ / shares	$ 10.33		$ 10.33					$ 10.33
Share Based Compensation Arrangement By Share Based Payment Award Number of Shares to Be Issued Upon Exercise of Outstanding Awards	3,391,000		3,391,000					3,391,000
Allocated Share-based Compensation Expense (in Dollars) | $	$ 1,411	$ 1,461	$ 2,664	$ 2,904
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense (in Dollars) | $	0	$ 0	0	$ 0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars) | $	$ 5,338		$ 5,338					$ 5,338
Employee Stock Purchase Plan [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,287,000		1,287,000					1,287,000
Equity Incentive Plans [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,055,000		1,055,000					1,055,000
Stock Appreciation Rights (SARs) [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	0	0
Restricted Stock Units (RSUs) [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	0	0
Maximum [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Exercisable, Number	1,951,000		1,951,000					1,951,000
Maximum [Member] | Stock Appreciation Rights (SARs) [Member]
Note 9 - Equity-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant As Percentage of Company S Outstanding Common Stock					75.00%	50.00%	66.67%	50.00%

Note 9 - Equity-Based Compens45

Note 9 - Equity-Based Compensation (Details) - Stock Options, SARs and RSUs Activity - Jun. 30, 2015 - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		Total	Total
Note 9 - Equity-Based Compensation (Details) - Stock Options, SARs and RSUs Activity [Line Items]
Weighted Average Remaining Contractual Term (years)	[1],[2]	3 years 262 days
Aggregate Value (in Dollars)	[2],[3]	$ 18,531	$ 18,531
Exercisable at June 30, 2015 (2)	[4]	2,491
Exercisable at June 30, 2015 (2) (in Dollars per share)	[4]	$ 7.5
Exercisable at June 30, 2015 (2)	[1],[4]	3 years 62 days
Exercisable at June 30, 2015 (2) (in Dollars)	[3],[4]	$ 7,938	$ 7,938
Options / SARs / RSUs cancelled/forfeited/expired			(2)
Options / SARs exercised and RSUs vested		(326)	(326)
Options / SARs exercised and RSUs vested (in Dollars per share)		$ 5.63	$ 5.63
Number of Options/SARs / RSUs	[2]	4,012	4,012
Weighted Average Exercise Price (in Dollars per share)	[2]	$ 5.97	$ 5.97
[1]	Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have indefinite contractual term.
[2]	Due to the ceiling imposed on the SAR grants, the outstanding amount above can be exercised for a maximum of 3,391,000 shares of the Company's common stock as of June 30, 2015. SAR grants made prior to January 1, 2009 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SARs subject to the grant. SAR grants made on or after January 1, 2009 and before January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 75% of the SARs subject to the grant. SAR grants made on or after January 1, 2010 and before January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 66.67% of the SARs subject to the grant. SAR grants made on or after January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SARs subject to the grant.
[3]	Calculation of aggregate intrinsic value is based on the share price of the Company's common stock on June 30, 2015 ($10.33 per share).
[4]	Due to the ceiling imposed on the SAR grants, the exercisable amount above can be exercised for a maximum of 1,951,000 shares of the Company's common stock as of June 30, 2015.

Note 9 - Equity-Based Compens46

Note 9 - Equity-Based Compensation (Details) - Company's Stock Options and SAR Units Outstanding and Exercisable - Jun. 30, 2015 - $ / shares shares in Thousands	Total
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options/ SARs / RSUs-Exercisable	2,491
Weighted Average Exercise Price -Exercisable	$ 7.50
Number of Options/ SARs / RSUs-Unexercisable	1,521
Weighted Average Exercise Price -Unexercisable	$ 3.47
Number of Options/ SARs / RSUs	4,012
Weighted Average Exercise Price	$ 5.97
Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options/ SARs / RSUs-Exercisable	100
Weighted Average Exercise Price -Exercisable	$ 19.27
Number of Options/ SARs / RSUs-Unexercisable	179
Weighted Average Exercise Price -Unexercisable	$ 11.20
Number of Options/ SARs / RSUs	279
Weighted Average Exercise Price	$ 14.09
Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options/ SARs / RSUs-Exercisable	2,391
Weighted Average Exercise Price -Exercisable	$ 7.01
Number of Options/ SARs / RSUs-Unexercisable	1,342
Weighted Average Exercise Price -Unexercisable	$ 2.43
Number of Options/ SARs / RSUs	3,733
Weighted Average Exercise Price	$ 5.37

Note 9 - Equity-Based Compens47

Note 9 - Equity-Based Compensation (Details) - Company's Stock Options and SAR Units Outstanding and Exercisable (Parentheticals)	Jun. 30, 2015$ / shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Share price	$ 10.33
Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Share price	10.33
Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Share price	$ 10.33

Note 10 - Pension Liability (De

Note 10 - Pension Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Defined Benefit Pension Plan, Liabilities, Noncurrent	$ 1,005	$ 1,089

Note 10 - Pension Liability (49

Note 10 - Pension Liability (Details) - Components of Net Pension and Post-Retirement Periodic Benefit Costs - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Components of net periodic benefit cost:
Service cost and amortization of loss	$ 12	$ 8
Interest cost	9	15
Expected return on plan assets	(2)	(3)
Net periodic benefit cost (income)	$ 19	$ (20)

Note 11 - Fair Value Measurem50

Note 11 - Fair Value Measurements (Details) - Fair Value Measurements of Assets and Liabilities on Recurring Basis - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Long-term marketable securities:
Derivative liabilities	$ 169	$ (618)
Fair Value, Measurements, Recurring [Member]
Long-term marketable securities:
Derivative liabilities	169	(618)
US Government-sponsored Enterprises Debt Securities [Member] | Fair Value, Measurements, Recurring [Member]
Short-term marketable securities and cash deposits:
Available For Sale Securities Debt Securities Current	1,499	1,499
Long-term marketable securities:
Available For Sale Securities Debt Securities Noncurrent	22,210	19,552
Corporate Debt Securities [Member] | Fair Value, Measurements, Recurring [Member]
Short-term marketable securities and cash deposits:
Available For Sale Securities Debt Securities Current	7,789	7,410
Long-term marketable securities:
Available For Sale Securities Debt Securities Noncurrent	69,996	72,717
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Cash equivalents:
Money market mutual funds	1,254	2,746
Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Cash equivalents:
Money market mutual funds	1,254	2,746
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]
Long-term marketable securities:
Derivative liabilities	169	(618)
Fair Value, Inputs, Level 2 [Member] | US Government-sponsored Enterprises Debt Securities [Member] | Fair Value, Measurements, Recurring [Member]
Short-term marketable securities and cash deposits:
Available For Sale Securities Debt Securities Current	1,499	1,499
Long-term marketable securities:
Available For Sale Securities Debt Securities Noncurrent	22,210	19,552
Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member] | Fair Value, Measurements, Recurring [Member]
Short-term marketable securities and cash deposits:
Available For Sale Securities Debt Securities Current	7,789	7,410
Long-term marketable securities:
Available For Sale Securities Debt Securities Noncurrent	$ 69,996	$ 72,717

Note 12 -Stockholders' Equity (

Note 12 -Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Stockholders' Equity Note [Abstract]
Treasury Stock, Shares, Acquired			550,027
Treasury Stock Acquired, Average Cost Per Share (in Dollars per share)			$ 11.54
Treasury Stock, Value, Acquired, Cost Method (in Dollars)	$ 4,899	$ 2,632	$ 6,346	$ 7,895
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	653,574		653,574
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures			701,000

Note 13 - Segment Information52

Note 13 - Segment Information (Details)	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
Number of Reportable Segments	3

Note 13 - Segment Information53

Note 13 - Segment Information (Details) - Selected Operating Results - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Segment Reporting Information [Line Items]
Revenue	$ 37,247	$ 36,276	$ 75,282	$ 69,162
Income (loss) from operations	2,860	3,187	5,586	4,208
Home [Member]
Segment Reporting Information [Line Items]
Revenue	32,055	32,495	66,406	63,200
Income (loss) from operations	7,112	6,290	14,288	10,895
Office [Member]
Segment Reporting Information [Line Items]
Revenue	5,192	3,781	8,876	5,962
Income (loss) from operations	(1,102)	(164)	(1,715)	(732)
Mobile [Member]
Segment Reporting Information [Line Items]
Income (loss) from operations	$ (3,150)	$ (2,939)	$ (6,987)	$ (5,955)

Note 13 - Segment Information54

Note 13 - Segment Information (Details) - Reconciliation of Segment Operating Results - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Reconciliation of Segment Operating Results [Abstract]
Income from operations	$ 2,860	$ 3,187	$ 5,586	$ 4,208
Unallocated corporate, general and administrative expenses	(503)	(561)	(1,141)	(1,133)
Equity-based compensation expenses	(1,411)	(1,461)	(2,664)	(2,904)
Intangible assets amortization expenses	(321)	(397)	(642)	(794)
Financial income, net	291	297	626	709
Total consolidated income before taxes	$ 916	$ 1,065	$ 1,765	$ 86

Note 13 - Accumulated Other C55

Note 13 - Accumulated Other Comprehensive Income (Details) - Changes in Accumulated Other Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (980)		$ (1,566)
Net current period other comprehensive income (loss)	50	$ 334	636	$ 212
Ending balance	(930)		(930)
Other comprehensive income before reclassifications	(100)		(25)
Amounts reclassified from accumulated other comprehensive income (loss)	150		661
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	146		(295)
Net current period other comprehensive income (loss)	(549)		(108)
Ending balance	(403)		(403)
Other comprehensive income before reclassifications	(549)		(134)
Amounts reclassified from accumulated other comprehensive income (loss)			26
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(430)		(618)
Net current period other comprehensive income (loss)	599		787
Ending balance	169		169
Other comprehensive income before reclassifications	454		162
Amounts reclassified from accumulated other comprehensive income (loss)	145		625
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(430)		(435)
Net current period other comprehensive income (loss)	5		10
Ending balance	(425)		(425)
Amounts reclassified from accumulated other comprehensive income (loss)	5		10
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(266)		(218)
Net current period other comprehensive income (loss)	(5)		(53)
Ending balance	(271)		(271)
Other comprehensive income before reclassifications	$ (5)		$ (53)

Note 13 - Accumulated Other C56

Note 13 - Accumulated Other Comprehensive Income (Details) - Reclassifications Out of Accumulated Other Comprehensive Income - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Financial income, net		$ 291	$ 297	$ 626	$ 709
Total, net of income taxes		730	1,088	1,503	100
Losses on cash flow hedges
Research and development	[1]	8,855	8,025	17,971	16,230
Sales and marketing	[2]	2,974	2,947	6,037	6,033
General and administrative	[3]	2,460	2,644	4,981	5,361
Total, before income taxes		916	$ 1,065	1,765	$ 86
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total, net of income taxes		150		661
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Financial income, net				26
Total, net of income taxes				26
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total, net of income taxes		145		625
Losses on cash flow hedges
Research and development		114		490
Sales and marketing		11		49
General and administrative		20		86
Total, before income taxes		145		625
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total, net of income taxes		5		10
Losses on cash flow hedges
Research and development		3		6
Sales and marketing		2		4
Total, before income taxes		$ 5		$ 10
[1]	Includes equity-based compensation expense in the amount of $613 and $657 for the three months ended June 30, 2015 and 2014, respectively; and $1,151 and $1,301 for the six months ended June 30, 2015 and 2014, respectively.
[2]	Includes equity-based compensation expense in the amount of $178 and $169 for the three months ended June 30, 2015 and 2014, respectively; and $330 and $331 for the six months ended June 30, 2015 and 2014, respectively.
[3]	Includes equity-based compensation expense in the amount of $537 and $551 for the three months ended June 30, 2014 and 2013, respectively; and $1,030 and $1,106 for the six months ended June 30, 2015 and 2014, respectively.

Note 14 - Government Grants (De

Note 14 - Government Grants (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Government Grants [Abstract]
Financial Grants in Support of Research and Development	$ 1,550	$ 1,156	$ 1,614	$ 2,037
Financial Grants in Support of Research and Development, Royalty Obligation	5.00%		5.00%

Uncategorized Items - dspg-2015

Label	Element	Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber	dspg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber	4,340
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingWeightedAverageExercisePrice	dspg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingWeightedAverageExercisePrice	$ 5.95